(IA) has improved and become more efficient. However, many patients still continue to experience serious negative impact on both their physical and psychosocial health and wellbeing. Therefore, it is essential to identify patients' needs for support for managing IA in everyday life. Objectives: To explore preferences for self-management and support services in patients with inflammatory arthritis. Methods: Adult patients with IA (rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA)) were invited through The Danish Rheumatism Organization, arthritis networks, and hospitals' rheumatology departments across the country to participate in a cross-sectional study using online survey methodology. The questionnaire included questions on patient's interest in participation (requiring an answer of yes or no) in a total of 30 different self-management and support services within eight overall categories (i.e. discussion groups, one-to-one sessions, question and answer sessions, organised talks, physical activity, education sessions, raising arthritis awareness events, and online services), and preferences regarding practical issues of taking part. Descriptive statistics were applied. Results: In total, 664 patients (85% female) responded, of which 53% had RA, 27% had PsA and 20% had axSpA. Respondents' mean age was 50 years (SD=13), and median disease duration was 10 years (IQR=4-16). Of the 30 different self-management and support services, the most popular was Online service: Website for information (about symptoms, treatment and selfmanagement of arthritis) with 91% of the respondents indicating interest. This was followed by One-to-one session with a rheumatologist (about coping with arthritis) (89%) and Organised talks by researchers (about current rheumatology research) (83%). Also, One-to-one session with a nurse, One-to-one session with a physiotherapist, and Education session on managing symptoms were all chosen by more than 80% of the respondents. The vast majority of respondents (81%) indicated to prefer a group with no fixed commitments and an advertised time table. Regarding timing of support, the majority (70%) indicated that selfmanagement and support services should optimally be offered whenever needed. However, respondents also stated it would be helpful within the first six months of being diagnosed (49%) as well as during flares (30%).
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Scientific Abstracts (IA) has improved and become more efficient. However, many patients still continue to experience serious negative impact on both their physical and psychosocial health and wellbeing. Therefore, it is essential to identify patients' needs for support for managing IA in everyday life. Objectives: To explore preferences for self-management and support services in patients with inflammatory arthritis. Methods: Adult patients with IA (rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA)) were invited through The Danish Rheumatism Organization, arthritis networks, and hospitals' rheumatology departments across the country to participate in a cross-sectional study using online survey methodology. The questionnaire included questions on patient's interest in participation (requiring an answer of yes or no) in a total of 30 different self-management and support services within eight overall categories (i.e. discussion groups, one-to-one sessions, question and answer sessions, organised talks, physical activity, education sessions, raising arthritis awareness events, and online services), and preferences regarding practical issues of taking part. Descriptive statistics were applied. Results: In total, 664 patients (85% female) responded, of which 53% had RA, 27% had PsA and 20% had axSpA. Respondents' mean age was 50 years (SD=13), and median disease duration was 10 years (IQR=4-16 Background: Enthesitis related arthritis (ERA) is an HLAB27-associated subtype of JIA most similar to the adult spondyloarthropathies (SpA). The innate immune system, intracellular stress response (the unfolded protein response (UPR)) and IL23/IL17 pathway are strongly implicated in the pathogenesis of adult SpA. However, these systems remain relatively unexplored in ERA. Objectives: To compare levels of the IL23 subunit, IL23p19, produced by monocyte-derived macrophages (MDMs) in the presence of lipopolysaccharide (LPS) and an inducer of the UPR (tunicamycin (TM)) from patients with ERA and healthy controls. Other pro-inflammatory cytokines and markers of the UPR were also studied. Methods: Peripheral blood monocytes isolated from 30 patients with ERA (20 HLAB27 positive, 10 HLAB27 negative, median age 16yrs 4mths, median disease duration 3yrs 9mths, M:F 7:1) and 16 age and gender-matched healthy controls were differentiated in vitro with macrophage-colony stimulating factor. Cells were treated with IFNγ and then stimulated with LPS alone or LPS with TM for 24 hours. Pro-inflammatory cytokines and markers of the UPR were measured by expression of mRNA using qPCR and normalised against GAPDH.
Abstract OP0057 - Background: Valid detection of inflamed joints is essential for correct classification, therapeutic decisions and assessment of treatment efficacy in juvenile idiopathic arthritis (JIA). Objectives: Fluorescence optical imaging (FOI) enables visualization of inflammation in arthritis of finger and hand joints and might be used in JIA. Methods: A 24-week observational study in polyarticular JIA patients newly starting treatment with either methotrexate or a biologic was performed. Patients were evaluated clinically, by ultrasound B-mode, power-Doppler and FOI at baseline, week 12 and 24. Results: Of 37 patients enrolled, 24 patients started MTX and 13 a biologic for the first time (Etanercept n=11, Adalimumab and Tocilizumab one 1). Composite measures, mean JADAS 10 decreased significantly from 17.7 at baseline to 12.2 and 7.2 at week 12 and 24 respectively and JIA-ACR 30/50/70/100 response rates at week 24 were 85%/73%/50%/27%. In total 1110 joints were examined clinically, 990 by US/PD and 990 by FOI. At baseline/week12/week24 23.6%/16.4%/9.0% joints on hand and fingers were clinically active joints, by US 19.4%/16.1%/11.5% joints showed effusions, 18.8%/12.7% and 9.6% showed synovial thickening and by PD 6.9%/1.8%/5% joints showed hyperperfusion. Any sign of arthritis was detected by US/PD in 24.5%/19.2%and17%. By FOI at 38.7%/29.2%/27.6% showed a signal enhancement in at least one phase. Summarizing all 3 points Figure 1 . FOI composite images of a 14 year old patient with polyarticular JIA at start of etanercept treatment (left), after 3 (middle) and 6 months (right).
